BIO-Europe 2007 to Tackle Most Urgent Issues Arising From Convergence of Biotech and Pharma.CARLSBAD, Calif. and MUNICH, Germany -- The leaders of the biotechnology industry will once again gather for BIO-Europe, the world's largest stand-alone partnering conference, in Hamburg Hamburg, city, Germany Hamburg (häm`b  rkh), officially Freie und Hansestadt Hamburg (Free and Hanseatic City of Hamburg), city (1994 pop. ,
Germany (November 12-14). This year's edition promises to set a new
standard for compelling and informative content necessary to discern
opportunities in an era of significant biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. industry change. Join many of the most respected thought leaders and decision makers in the industry and examine the issues, new business approaches and policy trends most important to the emerging biotech future. A central theme to BIO-Europe 2007 will be to understand the signs, symptoms and opportunities of the much-anticipated convergence of biotech and Big Pharma. Fundamental questions, such as how can biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. help the pharmaceutical industry meet double digit Noun 1. double digit - a two-digit integer; from 10 to 99 integer, whole number - any of the natural numbers (positive or negative) or zero; "an integer is a number that is not a fraction" growth expectations by contributing new products and processes, will be openly discussed and debated by some of the most notable names in the industry. A session destined des·tine tr.v. des·tined, des·tin·ing, des·tines 1. To determine beforehand; preordain: a foolish scheme destined to fail; a film destined to become a classic. 2. to shake up traditional wisdom and preconceived notions Noun 1. preconceived notion - an opinion formed beforehand without adequate evidence; "he did not even try to confirm his preconceptions" parti pris, preconceived idea, preconceived opinion, preconception, prepossession of the industry is entitled, "The Changing World Order of Biotech-Pharma - How Will Emerging Realities Affect Your Business Strategy?" Other conference highlights include the not to be missed 5th annual "A Day in the Life of Experienced Dealmakers" Plenary Session Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance. These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery. . Led by James Watson, Managing Director and Head of Merchant Banking, Burrill & Company and including industry notables as Thomas Hofstaetter, Senior Vice President of Corporate Development, Wyeth and John G. Goddard, Global Head and Senior VP of Strategic Planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. and Business Development, AstraZeneca, this highly popular and provocative forum promises to continue its tradition of lively and insightful debate over key issues of strategic deal making by some of the biggest names in biotech deal making. Notes to Editors: Entry to BIO-Europe 2007 is free to the media, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe conference website at http://www.ebdgroup.com/bioeurope for detailed information on this year's conference and online registration. When you register online, please indicate in the comment field that you are requesting a complimentary press registration. Please fax a copy of your press pass to complete your complimentary media registration to fax number +49 (89) 23 88 756 - 55. About BIO-Europe 2007 BIO-Europe 2007 is the preeminent pre·em·i·nent or pre-em·i·nent adj. Superior to or notable above all others; outstanding. See Synonyms at dominant, noted. [Middle English, from Latin prae partnering conference for the biotechnology industry. Delegates from all parts of the biotechnology value-chain come to BIO-Europe to efficiently identify, engage and enter into the strategic relationships that drive their business successfully forward. It is anticipated that this year's BIO-Europe partnering event will draw 2,000 industry attendees from almost 40 countries, representing over 1,000 companies for three days of high-level networking. BIO-Europe features the industry's most advanced Web based Coming from a Web server. See Web application. partnering system that delegates will use to generate in excess of 7,000 partnering meetings. BIO-Europe features an exceptional international exhibition where companies, organizations and biotech regions can showcase their offerings. Additional networking opportunities will abound at evening and special events. About EBD EBD Emotional or behavioral disorder Group EBD Group is the leading partnering firm for the global biotechnology industry. Since 1993, firms in the life sciences have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business. EBD Group's conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, the world's largest stand-alone life science partnering conference; BIO-Europe Spring; the investor conference, BioEquity Europe (co-organized with BioCentury Publications); and the convergent medical technology partnering conference, BioDevice Partnering. EBD's novel, web-based, partnering software system is also used at numerous third-party events around the world. Outside of the conference format, EBD Group's consultants can provide hands-on assistance for firms seeking to in- or out-license products and technologies. EBD Group has offices in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. , Munich and London. For more information visit www.ebdgroup.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion